Volta Medical

Volta Medical is a private, clinical-stage medtech company headquartered in Marseille, France, specializing in AI-powered software for cardiac electrophysiology. The company's core platform analyzes intracardiac electrograms in real-time to identify abnormal tissue substrates, aiming to improve the success rates of catheter ablation procedures for atrial fibrillation. While likely in early revenue stages from limited commercial use or studies, its primary focus is on achieving regulatory approvals and demonstrating clinical utility. Volta operates with a targeted geographic strategy, as evidenced by its separate U.S. and European web portals, indicating a focus on navigating specific regulatory pathways in key markets.

Proprietary AI and machine learning software that analyzes intracardiac electrogram (EGM) signals in real-time to identify abnormal atrial substrates during cardiac ablation procedures, providing visual guidance to electrophysiologists.

Volta competes in the emerging AI-for-EP space against both other specialized startups and the internal development efforts of large, incumbent medtech companies like Abbott, Johnson & Johnson (Biosense Webster), and Boston Scientific. These giants have extensive installed bases, sales forces, and integrated mapping system ecosystems, posing a significant barrier to entry.